Literature DB >> 8843291

In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.

J Gnarpe1, K Eriksson, H Gnarpe.   

Abstract

Fourteen isolates of Chlamydia pneumoniae, 12 from clinically ill patients and 2 from subjectively healthy individuals from an area within a 400-km proximity of Gävle, Sweden, and strain IOL-207, originally from the eye of an Iranian child, were tested for susceptibilities to the antibiotics doxycycline and azithromycin. MICs and minimum chlamydiacidal concentrations were found to correlate well with values reported earlier by other investigators. In addition to MIC and minimum chlamydiacidal concentration testing, testing for the viability of C. pneumoniae after exposure to antibiotic concentrations as high as 50 mg/liter was carried out by passaging antibiotic-treated, infected cell cultures four times in the absence of antibiotics. It was found that all Chlamydia strains were viable after four passages, regardless of antibiotic concentration in the cell culture.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843291      PMCID: PMC163427     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Infections caused by Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  Persistent infection with Chlamydia pneumoniae following acute respiratory illness.

Authors:  M R Hammerschlag; K Chirgwin; P M Roblin; M Gelling; W Dumornay; L Mandel; P Smith; J Schachter
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

Review 3.  Chlamydia pneumoniae, strain TWAR pneumonia.

Authors:  J T Grayston
Journal:  Annu Rev Med       Date:  1992       Impact factor: 13.739

4.  In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.

Authors:  R P Gladue; G M Bright; R E Isaacson; M F Newborg
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

5.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

6.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

7.  Tetracycline influence on leukocyte functions.

Authors:  J Belsheim; C Blomqvist; J Löfberg; H Gnarpe
Journal:  Acta Otorhinolaryngol Belg       Date:  1983

8.  Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.

Authors:  A E Girard; D Girard; A R English; T D Gootz; C R Cimochowski; J A Faiella; S L Haskell; J A Retsema
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  Tetracyclines and host defense mechanisms: interference with leukocyte chemotaxis.

Authors:  J Belsheim; H Gnarpe; S Persson
Journal:  Scand J Infect Dis       Date:  1979

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  5 in total

1.  Chlamydia pneumoniae infection in polarized epithelial cell lines.

Authors:  Liisa Törmäkangas; Eveliina Markkula; Kari Lounatmaa; Mirja Puolakkainen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

2.  In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniae.

Authors:  I Gustafsson; E Hjelm; O Cars
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinations.

Authors:  H M Freidank; P Losch; H Vögele; M Wiedmann-Al-Ahmad
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  Antimicrobial susceptibility testing of two Lawsonia intracellularis isolates associated with proliferative hemorrhagic enteropathy and porcine intestinal adenomatosis in South Korea.

Authors:  Jung-Yong Yeh; Ji-Hye Lee; Hye-Ryun Yeh; Aeran Kim; Ji Youn Lee; Jeong-Min Hwang; Bo-Kyu Kang; Jong-Man Kim; In-Soo Choi; Joong-Bok Lee
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

Review 5.  Azithromycin. A review of its use in paediatric infectious diseases.

Authors:  H D Langtry; J A Balfour
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.